Literature DB >> 15122210

C/EBPalpha mutations in acute myeloid leukaemias.

Claus Nerlov1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15122210     DOI： 10.1038/nrc1363

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  99 in total

1.  Expression of the transcriptional repressor Gfi-1 is regulated by C/EBP{alpha} and is involved in its proliferation and colony formation-inhibitory effects in p210BCR/ABL-expressing cells.

Authors:  Maria Rosa Lidonnici; Alessandra Audia; Angela Rachele Soliera; Marco Prisco; Giovanna Ferrari-Amorotti; Todd Waldron; Nick Donato; Ying Zhang; Robert V Martinez; Tessa L Holyoake; Bruno Calabretta
Journal:  Cancer Res       Date:  2010-10-05       Impact factor: 12.701

2.  Repression of transcriptional activity of C/EBPalpha by E2F-dimerization partner complexes.

Authors:  Katrin Zaragoza; Valérie Bégay; Anja Schuetz; Udo Heinemann; Achim Leutz
Journal:  Mol Cell Biol       Date:  2010-02-22       Impact factor: 4.272

3.  Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1.

Authors:  Bas J Wouters; Meritxell Alberich Jordà; Karen Keeshan; Irene Louwers; Claudia A J Erpelinck-Verschueren; Dennis Tielemans; Anton W Langerak; Yiping He; Yumi Yashiro-Ohtani; Pu Zhang; Christopher J Hetherington; Roel G W Verhaak; Peter J M Valk; Bob Löwenberg; Daniel G Tenen; Warren S Pear; Ruud Delwel
Journal:  Blood       Date:  2007-08-01       Impact factor: 22.113

Review 4.  C/EBPα deregulation as a paradigm for leukemogenesis.

Authors:  J A Pulikkan; D G Tenen; G Behre
Journal:  Leukemia       Date:  2017-07-19       Impact factor: 11.528

5.  Highly efficient genome editing of human hematopoietic stem cells via a nano-silicon-blade delivery approach.

Authors:  Yuan Ma; Xin Han; Oscar Quintana Bustamante; Ricardo Bessa de Castro; Kai Zhang; Pengchao Zhang; Ying Li; Zongbin Liu; Xuewu Liu; Mauro Ferrari; Zhongbo Hu; José Carlos Segovia; Lidong Qin
Journal:  Integr Biol (Camb)       Date:  2017-06-19       Impact factor: 2.192

6.  Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome.

Authors:  Bas J Wouters; Bob Löwenberg; Claudia A J Erpelinck-Verschueren; Wim L J van Putten; Peter J M Valk; Ruud Delwel
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

Review 7.  Dysregulation of the C/EBPalpha differentiation pathway in human cancer.

Authors:  Steffen Koschmieder; Balazs Halmos; Elena Levantini; Daniel G Tenen
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

8.  C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.

Authors:  Thomas Sebastian; Radek Malik; Sara Thomas; Julien Sage; Peter Frederick Johnson
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

9.  The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages.

Authors:  Hiromi Iwasaki; Shin-ichi Mizuno; Yojiro Arinobu; Hidetoshi Ozawa; Yasuo Mori; Hirokazu Shigematsu; Kiyoshi Takatsu; Daniel G Tenen; Koichi Akashi
Journal:  Genes Dev       Date:  2006-11-01       Impact factor: 11.361

10.  C/EBPβ expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway.

Authors:  Natasa Anastasov; Irina Bonzheim; Martina Rudelius; Margit Klier; Therese Dau; Daniela Angermeier; Justus Duyster; Stefania Pittaluga; Falko Fend; Mark Raffeld; Leticia Quintanilla-Martinez
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.